Clinical Trial Update: Trial to Model Primary, Secondary, and Tertiary Dengue Using a Monovalent Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of a monovalent dengue vaccine to model primary, secondary, and tertiary dengue exposure is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Monovalent dengue vaccine (investigational)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Response To Dengue Exposure | Phase 1 | Status: ACTIVE_NOT_RECRUITING